Chandan Healthcare IPO Review: Apply or Avoid?

Posted by : sachet | Fri Feb 07 2025

Chandan Healthcare IPO Review: Apply or Avoid?

The Chandan Healthcare IPO is set to open for bidding on 10th February 2025 at 10 AM.  The offer is a completely book-built issue with a total issue size of ₹107.36 Cr. The Chandan Healthcare IPO is set to be listed on the Indian markets on 17th February 2025 (tentatively). 

The public issue is a combination of a fresh issue of 44.52 lakh shares and an offer for sale (OFS) of 23.00 lakh shares. 

Chandan Healthcare IPO Details 

Chandan Healthcare IPO is being offered for subscription to the Indian markets starting on 10th February 2025 with a price band of ₹ 151 as a floor price and ₹ 159 as a cap price. The minimum lot size is set at 800 per share, aggregating to a minimum application amount of ₹ 1,27,200 (cap price * minimum lot size). 

The allotment basis for Chandan Healthcare IPO  will be decided on 13th February 2025, and the refund initiation and credit of shares in a bank account is set to take place on 14th February 2025. 

The book-running lead manager for the Chandan Healthcare IPO is Unistone Capital Private Limited. Kfin Technologies Limited is the registrar for the issue and R.K. Stock Holding Private Limited. is the market maker for the IPO. Refer to the below table for more details about the Chandan Healthcare IPO:

IPO Open Date10th February 2025 
IPO Close Date12th February 2025
Basis of Allotment 13th February 2025
Refund Initiation & Credit of Shares 14th February 2025
Listing Date17th February 2025
Issue Size (in value)₹107.36 Cr
Issue Size (in shares)67,52,000 shares
Face Value₹ 10 per share
Lot Size800 shares 
Price Band ₹ 151 – ₹ 159 
Issue TypeBook Built Issue
Listing AtNSE SME

Chandan Healthcare IPO GMP, Issue Size, Price, and Offer Details

Chandan Healthcare IPO, an NSE SME IPO is likely to be listed on the Indian stock exchanges on 17th February 2025. The minimum subscription for  Chandan Healthcare IPO is as follows:

Investor CategoriesReservation Required 
QIB<50% of total issue
Retail Investors>35% of total issue
NII (sNII+bNII)>15% of total issue
Total100%

Chandan Healthcare IPO GMP (Grey Market Premium)

Chandan Healthcare IPO GMP: Grey Market Premium (GMP) refers to the price of an IPO trailing in the grey markets. It also refers to the difference between the issue price and the grey market price of an IPO.

As per the recent data available on 7th February of 2025, Chandan Healthcare IPO GMP currently stands at a price of ₹ 14. This GMP value indicates a premium debut of Chandan Healthcare Limited at an estimated listing price of ₹ 173. The estimated listing gains are estimated at 8.81%.

GMP Date[A]GMP ()[B]Cap Price ()[A+B]Estimated Listing Price (Estimated Listing Gains (%)
07-02-2025₹ 14 ₹ 159₹ 173 8.81
06-02-2025₹ 14 ₹ 159₹ 1738.81
05-02-2025₹ 0₹ 159₹ 1590.00
04-02-2025₹ 0₹ 159₹ –0.00
03-02-2025₹ 0₹ 159₹ –0.00

*Data is updated as of 7th February 2025. 

Chandan Healthcare IPO Bidding Requirements

Chandan Healthcare IPO is offered with minimum bidding requirements of 800 shares and in multiples thereof. Refer to the below table for more details about the bidding requirements of Chandan Healthcare IPO

Investors Category Lots Minimum shares (A)Cap Price (B)Amount (A*B)
Retail (Min)1800₹ 159₹ 1,27,200
Retail (Max) 1800₹ 159₹ 1,27,200
HNI (Min)21600₹ 159₹ 2,54,400

Chandan Healthcare IPO Review

Before investing in a company through its initial public offering, it is important to research and analyse the fundamentals and technical aspects of investing safely in the IPO. Therefore, if you want to make a sound investment decision regarding the Chandan Healthcare IPO, ensure that you read the details below about the company: 

Financial Health

Chandan Healthcare Limited has experienced consistent growth in revenue since FY 31st March 2022. The company earned a total revenue (other income + revenue from operation ) of 11,991.58 lakh, which grew by 14.27% to 13,702.92 laksh in FY 2023. IN FY 2024, the total revenue of Chandan Healthcare was 17,795.86 lakhs. 

On the profit side, the company’s profit also grew consistently from FY 2022 to FY 2024. The company had a weak performance in FY 2022 and booked a loss of 109.26 lakhs, whereas in FY 2023, the profit grew to 358.63 lakhs, and in FY 2024 the profit of the company stood at a figure of 1,635.50 lakhs. 

Technical Analysis

A number of technical indicators are available to assess the stock’s potential for the coming time. You can analyse the potential of Chandan Healthcare IPO with the help of the technical indicators mentioned below. 

Key IndicatorsValue
P/E Ratio (Pre-IPO)19.44
D/E Ratio (Debt to Equity)1.02
EPS (Pre-IPO)8.18
RONW39.54%
ROE (Return on Equity)47.50%
ROCE35.20%
PAT Margin (Profit After Tax)9.26

*Data is updated as of 7th February 2025. 

The PE ratio of Chandan Healthcare Limited shares is 19.44, and its Earnings Per Share (pre-IPO) stands at 8,18. It indicates that the IPO has a high potential to deliver short and long-term returns. 

Chandan Healthcare Limited has shown considerable growth in its financial performance and has portrayed itself as a strong candidate for SME IPO investment.  Also, the technical ratios of Chandan Healthcare Limited depict that it has the potential for substantial growth in the future. However, these performances figure do not guarantee profits in Chandan Healthcare IPO investments therefore, it is advisable that you do not invest in the public issue without performing extensive research. 

Objectives of Chandan Healthcare IPO 

Chandan Healthcare Limited is raising approximately ₹ 107.36crores from the IPO to meet various business and corporate objectives in the coming future. The aim and allocation of the Chandan Healthcare IPO is as follows:

Particular Estimated Amount ()
Setting up of a new Flagship diagnostic centre in Jankipuram, Lucknow, Uttar Pradesh.3,281.58
Setting up of a new Central Reference laboratory at Ayodhya,Uttar Pradesh.710.23
Setting up of a new Central Reference laboratory at Ashiyana,Lucknow, Uttar Pradesh.710.11
General corporate purposes*

(fgures in lakhs)

*The amount will be decided after the determination of the offer price and the amount to be used for general corporate purposes can not exceed 25% of the Gross Proceeds. 

About Chandan Healthcare Limited 

Chandan Healthcare Limtied is involved in the business of running testing laboratories in North India.  As of 31st December 2024, the company provides a wide array of test aggregating to a total of 1,496 across different specialists. Chandan Healthcare Limited has a test menu of (a) 481 routine pathology tests, covering basic biochemistry and hematology, as well as 1,015 specialised pathology tests, (b) 545 radiology tests, including basic x-rays, ultrasonography, computed tomography, magnetic resonance imaging and specialised CT scans 

The company has a group of 15 radiologists, 23 pathologists, and more than 161 qualified professionals, including clinicians, technicians and operators. The company operates on a cluster and collections points model, i.e. grouping nearby patients and laboratories or clinics into clusteer and collecting samples at those diagnosed points, then transporting them in bulk to a central laboratory for processing. 

Chandan Healthcare Limited Financial Performance 

                                                                                                                           (Figures are in Lakhs)

Particulars Fiscal Year 2024 Fiscal Year 2023 Fiscal Year 2022
Revenue From Operations ₹ 17,659.01₹ 13,688.94₹ 11,956,35
EBDITA₹ 2,610.28 ₹ 927.41₹ 215.75
PAT ₹ 1,635.51 ₹ 358.63₹ (109.25)
Pat Margin (%)9.26%2.62%(0.91)%
Net Worth ₹ 4,116.07₹ 2,736.87 ₹ 2,400.07 

How to Apply for Chandan Healthcare IPO  

To apply for the Chandan Healthcare IPO, you simply need to follow the below steps: 

  1. Research the risks, benefits, and key details of the public offer. 
  2. Open a demat account with Univest to know more about the IPO and invest in it. If you have an old demat account, you can also use it to invest in the IPO. 
  3. If you are a retail investor, then place a bid of 800 shares for a total amount of ₹ 1,27,200.
  4. Once the bidding process is completed, you will receive a request for payment initiation on your chosen investment method. Approve the payment request and stay updated with the allotment status for the Chandan Healthcare IPO.  

Let’s Wrap

  • Chandan Healthcare IPO will be open for bidding on 10th February 2025 and will close on 12th February 2025. 
  • The total size of Chandan Healthcare Limited  IPO is 67,52,000 shares shares, aggregating to ₹ 107.36 crores. 
  • The public offer is a book-built issue and consists completely of a fresh issue of 67.52 lakh shares. 
  • The last updated grey market premium of Chandan Healthcare IPO is ₹ 14.
  • The price band of Chandan Healthcare IPO is set with a floor price of ₹ 150 and a cap price of ₹ 159. 

FAQ on Chandan Healthcare IPO

1. What is the price of the Chandan Healthcare IPO?

The price band of Chandan Healthcare IPO is ₹ 150 to ₹ 159. It is a 100% book-built issue of ₹ 107.36 crores, which is set for bidding on 10th February 2025 and will close on 12th February 2025. 

2. How can I check Chandan Healthcare’s IPO status?

You can check the status of Chandan Healthcare IPO either on the official website of the National Stock Exchange or through your registered stockbroking platform. 

3. What is the GMP of Chandan Healthcare IPO?

The latest updated GMP of the Chandan Healthcare IPO as of 7th February 2025 is ₹ 14. 

4. What is Chandan Healthcare Limited’s business?

Chandan Healthcare Limited is involved in the business of providing a wide range of test services to customers in North India through its laboratories. 

Open a demat account on Univest now to initiate your investment journey. Explore the Univest terms and conditions by clicking on the link

Disclaimer: The above information is accumulated from authentic sources and is just for informational purposes. To have detailed information about Chandan Healthcare IPO, download the Chandan Healthcare IPO RHP and IPO DRHP. Conduct your own research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Read Our Articles on the Best Stocks

Best FMCG Stocks in India 2025 

Best Green Energy Stocks By Market Capitalsation 

Top 10 Chemical Stocks By Market Capitalisation

Best Fundamentally Strong Stocks For Long Term

Top Green Energy Stocks in Buy In 2025 

Fundamentally Strong Stocks In BSE 

Diamond Company Stocks in India: Top Picks for 2025

Explore Current and Previous IPOs

CompanyOpening Date Closing Date
Solarium Green Energy Limited6th February 2025 10th February 2025
Amwill Healthcare Limited 5th February 2025 7th February 2025 
Ken Enterprises Limited 5th February 2025 7th February 2025 
Chamunda Electricals Limited4th February 20256th February 2025
Malpani Pipes and Fitting Ltd29th January 2025 31st January 2025 
Dr. Agarwals Healthcare Ltd. 29th January 2025 31st January 2025
H.M. Electro Mech Ltd.24th January 2025 28th January 2025 
Denta Water and Infra Solutions Ltd. 22nd January 2025 24th January 2025
Stallion India Fluorochemicals Ltd. 16th January 2025 20th January 2025 

52-Week Low Stocks Today

Stocks LTP (₹)New Low (₹)
Swiggy Limited 380.65375.00
Tube Investment of India Limited2,909.852,890.00
Brainbees Solutions Limited 418.40411.05
Hathway Cables & Datacom Limited 14.7012.61
Rajesh Exports Limited 181.36150.53

52 Week High Stocks Today 

Stocks LTP (₹)New High  (₹)
Aarti Pharmalabs Limited740.85669.75
Lauras Labs Limited 641.35633.90
Vimta Labs Limited1,031.201,019.10
Blue Jet Healthcare Limited 821.75801.40
Wonder Electricals Limited 198.18182.81

*Data is updated as of 7th January 2025 

Univest Screeners

ExclusiveIndicesBreakouts
Buy in Short TermNifty Small Cap 100Daily Fresh Breakouts
Buy in Long TermNifty MidcapWeekly Breakouts
FII Holdings ChangeNifty BankOversold Stocks
Golden CrossoverSensexNearing Breakout
Upcoming DividendsNifty Fin Service
DII Holdings ChangeBankex
High Dividend StocksNifty Mid Cap 100
Earnings AnnouncedNifty 50
Fundamentally Strong 
Top Gainers
Top Losers
Low Debt Mid Caps
Cash-Rich Small Caps
Volume Shockers
52-Week High 
52-Week Low

Popular Stocks to Consider 

Stock NameNSE Symbol 
Abbott India Ltd.ABBOTINDIA
Adani Total Gas Ltd.ATGL
Aegis Logistics Ltd.AEGISLOG
Apollo Hospitals Enterprise Ltd.APOLLOHOSP
Apollo Tyres Ltd.APOLLOTYRE
Ashok Leyland Ltd.ASHOKLEY
AU Small Finance Bank Ltd.AUBANK
Aurobindo Pharma Ltd.AUROPHARMA
Axis Bank Ltd.AXISBANK
Bajaj Auto Ltd.BAJAJAUTO
Bajaj Finance Ltd.BAJAJFINANCE
Balkrishna Industries Ltd.BALKRISIND
Bank of Baroda Ltd.BANKBARODA
Biocon Ltd.BIOCON
Brigade Enterprises Ltd.BRIGADE
Britannia Industries Ltd.BRITANNIA
Canara Bank Ltd.CANBK
Castrol India LtdCASTROLIND
Cholamandalam Investment and Finance Company Ltd.CHOLAFIN
Coforge Ltd.COFORGE
Den Networks Ltd.DEN
Dish TV India Ltd.DISHTV
Divis Laboratories Ltd.DIVISLAB
Dr Reddy’s Laboratories Ltd.DRREDDY
Eicher Motors Ltd.EICHERMOT
Exide Industries Ltd.EXIDEIND
Federal Bank Ltd.FEDERALBNK
GAIL (India) Ltd.GAIL
Gland Pharma Ltd.GLAND
Glenmark Pharmaceuticals Ltd.GLENMARK
Godrej Consumer Products Ltd.GODREJCP
Godrej Properties Ltd.GODREJPROP
Granules India Ltd.GRANULES
Gujarat Gas Ltd.GUJGASLTD
Gujarat State Petronet Ltd.GSPL
Hathway Cable & Datacom Ltd.HATHWAY
HCL Technologies Ltd.HCLTECH
HDFC Assets Management Company Ltd.HDFCAMC
Hero MotoCorp Ltd.HEROMOTOCO
Hindustan Petroleum Corporation Ltd.HINDPETRO
ICICI Bank Ltd.ICICIBANK
ICICI Lombard General Insurance Company Ltd.ICICIGI
ICICI Prudential Life Insurance Company Ltd.ICICIPRULI
IDFC First Bank Ltd.IDFCFIRSTB
Indian Oil Corporation Ltd.IOC
Infosys Ltd.INFY
IPCA Laboratories Ltd.IPCALAB
J.B. Chemicals & Pharmaceuticals Ltd.JBCHEPHARM
Kotak Mahindra Bank Ltd.KOTAKBANK
L&T Technology Services Ltd.LTTS
Laurus Labs Ltd.LAURUSLABS
LIC Housing Finance Ltd.LICHSGFIN
LTI Mindtree Ltd.LTIM
Lupin Ltd.LUPIN
Macrotech Developers Ltd.LODHA
Mahangar Gas Ltd.MGL
Mahindra & Mahindra Ltd.M&M
Mahindra Lifespace Developers Ltd.MAHILIFE
Mankind Pharma Ltd.MANKIND
Marico Ltd.MARICO
Metropolis Healthcare Ltd.METROPOLIS
Mphasis Ltd.MPHASIS
MRF Ltd.MRF
Muthoot Finance Ltd.MUTHOOTFIN
NATCO Pharma Ltd.NATCOPHARM
Nazara Technologies Ltd.NAZARA
Nestle India Ltd.NESTLEIND
Oberoi Realty Ltd.OBEROIRLTY
Persistent Systems Ltd.PERSISTENT
Petronet LNG Ltd.PETRONET
Phoenix Mills Ltd.PHOENIXLTD
Power Finance Corporation Ltd.PFC
Prestige Estates Projects Ltd.PRESTIGE
Procter & Gamble Hygiene & Health Care Ltd.PGHH
Punjab National Bank Ltd.PNB
PVR INOX Ltd.PVRINOX
Radico Khaitan Ltd.RADICO
Raymond Ltd.RAYMOND
Saregama India Ltd.SAREGAMA
SBI Cards and Payment Services Ltd.SBICARD
SBI Life Insurance Company Ltd.SBILIFE
Sobha Ltd.SOBHA
State Bank of India Ltd.SBIN
Sun TV Network Ltd.SUNTV
Syngene International Ltd.SYNGENE
Tata Consultancy Services Ltd.TCS
Tata Consumer Products Ltd.TATACONSUM
Tata Motors Ltd.TATAMOTORS
Tech Mahindra Ltd.TECHM
Tips Music Ltd.TIPSMUSIC
Titan Company LimitedTITAN
Torrent Pharmaceuticals Ltd.TORNTPHARM
United Breweries Ltd.UBL
United Spirits Ltd.UNITDSPR
Varun Beverages Ltd.VBL
Wipro Ltd.WIPRO
Yes Bank LimitedYESBANK
Zee Entertainment Enterprises Ltd.ZEEL
Zomato LimitedZOMATO
Zydus Lifesciences Ltd.ZYDUSLIFE
icon

100% Safe & Secure Platform.

Univest encrypts all data and transactions to ensure a completely secure experience for our members.

Copyright

2025 Univest. All rights reserved. | Designed with ❤️ in India
About Univest
About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
 
Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
 
Univest Stock Broking Disclosures
Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
 Risk Disclosures on Derivatives
1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
2. On an average, loss makers registered net trading loss close to ₹ 50,000
3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
Investors are further cautioned to avoid practices like:
a. Sharing 
i) trading credentials – login id and passwords including OTPs.
ii) trading strategies,
iii) position details.
b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
 Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
arrow down